TAFFA N TMUSNIWIN TUSNANIN

Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations

National Advisory Committee on ImmunizationAselkim2023Asuffeɣ unṣib

Agzul n yisemli ASEM

Official National Advisory Committee on Immunization document (2023) on “Summary of National Advisory Committee on Immunization statement of March 2023: Interim guidance on the use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations”. Summary of NACI guidance on safety and recommended use of pneumococcal 15-valent conjugate vaccine (PNEU-C-15) in pediatric populations in Canada.

Agzul-a ad k-yefk tallalt deg unadi ɣef uttaft. I wellihen klinik, ẓer yal tikkelt lqem unṣib amiran akked uzemz n uleqqem-is.

Isemli unṣib

Iwellihen yeqqnen

Summary of NACI statement of May 2026: Statement on seasonal influenza vaccines for 2026-2027 Summary of NACI statement of June 2026: Guidance on the use of COVID-19 vaccines starting fall 2026 Summary of updates in the Canadian Immunization Guide as of March 31, 2025: Updated guidance on quadrivalent conjugate meningococcal vaccines available in Canada